Skip to content
Assyro AI
Assyro eCTD

New Drug Submission (NDS) Software, Health Canada eCTD

Build the NDS, its Canadian Module 1, and every follow-up sequence in one eCTD lifecycle. For sponsors filing in-house and consultancies filing for clients.

NDS Filing Workflow

See where NDS filings lose time across drafting, review, validation, and readiness.

  • Write the Canadian Module 1 for Each NDS Sequence

    Assyro writes ca-regional.xml to Health Canada's Module 1 schema 2.2 with the NDS regulatory activity type.

  • Stop Schema Errors Before the Build

    A Module 1 that does not match the Canadian schema is stopped before the sequence is built.

  • Validate Against Health Canada's Rules

    Each sequence is checked against Health Canada's eCTD validation rules, version 5.3.

  • Keep the Lifecycle in Order

    Each sequence records the sequence it relates to, so the dossier's history stays readable.

NDS Filing Controls and Capacity

Keep submission growth controlled with clearer ownership, better traceability, and consistent execution across active programs.

  • Maintain Audit-Ready NDS Records

    NDS sequences are checked against Health Canada's Module 1 schema 2.2 and eCTD validation rules version 5.3, with audit trails and role-based access.

  • Manage More NDS Programs With the Same Team Size

    Track Health Canada correspondence and commitments in Assyro RIM

Questions About NDS Submission Software

Practical questions sponsors and consultancies ask about Health Canada NDS filings.

Agent CTA Background

See Your Next NDS Sequence in Assyro.